resistant ovarian cancer

Related by string. * RESISTANT . Resistant . resistants : Mine Resistant Ambush Protected . antibiotic resistant bacteria . herbicide resistant weeds . scratch resistant / Ovarian . OVARIAN : recurrent ovarian cancer . relapsed ovarian cancer . ovarian tissue / CANCER . www.cancer . Cancer : San Antonio Breast Cancer . American Cancer Society . Breast Cancer Awareness Month * *

Related by context. Frequent words. (Click for all words.) 67 HRPC 66 hormone refractory prostate cancer 65 carboplatin 65 AP# [003] 64 metastatic melanoma 64 metastatic colorectal cancer 64 NSCLC 64 chronic lymphocytic leukemia CLL 64 docetaxel 63 solid tumors 63 cisplatin 63 Perifosine 63 chemotherapy regimens 63 advanced NSCLC 63 taxane 63 gemcitabine 62 antitumor activity 62 T DM1 62 sunitinib 61 cutaneous T cell 61 adjuvant therapy 61 anticancer agents 61 HER2 positive breast cancer 61 trastuzumab 61 bone metastases 61 hematological malignancies 60 IMGN# 60 chemotherapeutic agent 60 perifosine 60 bortezomib 60 voreloxin 60 metastatic breast cancer 59 anti TNF 59 erlotinib 59 cell lung cancer 59 temozolomide 59 monotherapy 59 Atiprimod 59 humanized monoclonal antibody 59 vandetanib 58 cetuximab 58 taxanes 58 gefitinib 58 ALCL 58 anthracyclines 58 relapsing remitting multiple sclerosis 58 cytarabine 58 renal cell carcinoma 58 chemotherapeutic agents 58 dasatinib 58 brain metastases 58 MGCD# [001] 58 Phase 2a clinical 58 chemotherapeutic 57 picoplatin 57 malignancies 57 hematologic malignancies 57 bevacizumab 57 5 fluorouracil 57 randomized Phase 57 free survival PFS 57 metastatic 57 metastatic disease 57 follicular lymphoma 57 pemetrexed 57 oxaliplatin 57 mCRC 57 Cell Lung Cancer 57 adjuvant chemotherapy 57 chronic myeloid leukemia CML 57 systemic lupus erythematosus 57 Alpharadin 56 myelofibrosis 56 kinase inhibitor 56 tumor recurrence 56 chemotherapy regimen 56 Phase 2b clinical 56 hormone receptor positive 56 Phase 2a trial 56 Satraplatin 56 TREANDA 56 imatinib 56 rituximab 56 HER2 positive 56 ASA# 56 phase IIb 56 cell malignancies 56 metastatic cancer 56 fluorouracil 56 evaluable 56 investigational compound 55 pralatrexate 55 carfilzomib 55 doxorubicin 55 elesclomol 55 FOLOTYN 55 ENMD 55 liver metastases 55 capecitabine 55 invasive bladder 55 cyclophosphamide

Back to home page